This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Lamers, Leida M.
van Vliet, Rene C. J. A.
Abstract

No abstract is available for this item.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help file. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.sciencedirect.com/science/article/B6V8X-4B0SY64-2/2/8c389e2d2f3695e4f25c38714e42c938
File Format:
File Function:
Download Restriction: Full text for ScienceDirect subscribers only

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Publisher Info
Article provided by Elsevier in its journal Health Policy.

Volume (Year): 68 (2004)
Issue (Month): 1 (April)
Pages: 113-121
Download reference. The following formats are available: HTML, plain text, BibTeX, RIS (EndNote), ReDIF
Handle: RePEc:eee:hepoli:v:68:y:2004:i:1:p:113-121

Contact details of provider:
Web page: http://www.elsevier.com/locate/healthpol

For technical questions regarding this item, or to correct its listing, contact: (Heidi Boesdal) or ().

Related research
Keywords:

Cited by:
(explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)

  1. Manuel García-Goñi & Pere Ibern, 2008. "Predictability of drug expenditures: an application using morbidity data," Health Economics, John Wiley & Sons, Ltd., vol. 17(1), pages 119-126. [Downloadable!]
  2. Lieke H. H. M. Boonen & Frederik T. Schut & Xander Koolman, 2008. "Consumer channeling by health insurers: natural experiments with preferred providers in the Dutch pharmacy market," Health Economics, John Wiley & Sons, Ltd., vol. 17(3), pages 299-316. [Downloadable!]
  3. Manuel García-Goñi & Pere Ibern, 2006. "Predictability of drug expenditures: an application using morbidity data," Economics Working Papers 977, Department of Economics and Business, Universitat Pompeu Fabra. [Downloadable!]
  4. Manuel García-Goñi & Pere Ibern, 2006. "Predictability of drug expenditures: an application using morbidity data," Working Papers, Research Center on Health and Economics 977, Department of Economics and Business, Universitat Pompeu Fabra. [Downloadable!]
Statistics
Access and download statistics

Did you know? A tutorial is available.

This page was last updated on 2009-1-6.

This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.